Yahoo Finance

Johnson & Johnson to acquire cardiovascular specialist V-Wave for up to $1.7bn

Johnson & Johnson (J&J) will acquire heart failure implant company V-Wave in a deal worth a potential $1.7bn, marking the latest billion-dollar boost to the medtech giant's cardiovascular device ...
Yahoo Finance

Johnson & Johnson to Acquire V-Wave for $1.1 Billion

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MM&M

J&J buys heart disease med device maker V-Wave in potential $1.7B deal

Johnson & Johnson announced the acquisition of heart disease medical device maker V-Wave in a deal worth up to $1.7 billion. Announced Tuesday, the transaction involves J&J paying $600 million upfront ...
Business Insider

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

CAESAREA, Israel, April 26, 2018 /PRNewswire/ -- V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with ...
PMLiVE

J&J to expand cardiovascular capabilities with V-Wave acquisition worth up to $1.7bn

Johnson & Johnson (J&J) has announced that it will be acquiring medical device company V-Wave in a deal worth up to $1.7bn. The agreement will give J&J’s medtech division access to a cardiovascular ...
Anadolu Ajansi

Johnson & Johnson to buy medical device company V-Wave for up to $1.7B

US-based pharmaceutical company Johnson & Johnson said Tuesday that it will acquire V-Wave, a medical device company focusing on patients with heart failure, for up to $1.7 billion. The agreement ...
Nasdaq

Johnson & Johnson To Acquire V-Wave For Initial Payment Of $600 Mln

(RTTNews) - Tuesday, Johnson & Johnson (JNJ) announced a definitive agreement to acquire V-Wave Ltd., for an initial payment of $600 million, with the potential for additional payments totaling up to ...
Business Wire

First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet

CAESAREA, Israel--(BUSINESS WIRE)--V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today the results of its first human ...
BioWorld

J&J pumps up cardiac commitment with $1.7B V-Wave acquisition

Johnson & Johnson (J&J) aims to add a fourth cardiac business to its portfolio in less than two years with the acquisition of V-Wave Ltd., which makes the Ventura interatrial shunt system for the ...
TCTMD

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

A novel percutaneously implanted unidirectional shunt for the treatment of systolic HF showed promising safety and efficacy outcomes at 3 months, according to new findings presented at TCT 2015. The ...
FierceBiotech

V-Wave nets $98M to advance its pressure-relieving shunt implant for heart failure

The series C proceeds will continue to fund V-Wave's work on Ventura, in addition to supporting the development of a new, adjustable-size version of the shunt. (Pixabay) () V-Wave has raised $98 ...
Yahoo Finance

Johnson & Johnson to Acquire V-Wave

V-Wave’s Novel and Minimally Invasive Interatrial Shunt is Designed to Treat Heart Failure and Addresses Significant Treatment Gap Device Further Strengthens Johnson & Johnson MedTech’s Position in ...